Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Scrip Asia 100 - Policy & Regulation
Scrip Asia 100 logo

2024 Scrip Asia 100

Latest Updates And Considerations In Asia Pacific

Policy & Regulation

Amid the evolving regulatory landscape, small molecule innovation is impacted by the Inflation Reduction Act (IRA), China is hit with compliance crackdowns and India’s reign on e-pharmacies is questioned.

Big Pharma R&D Chiefs On IRA’s Unintended Casualty, Product Life Cycle Compression

R&D heads of Takeda, Amgen, Lilly and Novartis discuss some of the tectonic forces shaping the biopharma sector and the unintended consequences of the IRA on small molecule innovation. Advances in the neurodegenerative diseases segment amid impressive data from donanemab was another key talking point.

Research & Development Pricing Debate Innovation

Storm Coming? Commercial Compliance Crackdown Shocks China Pharma Industry

In a new wave of crackdowns on compliance in the pharma sector in China, 10 medical meetings have been cancelled in short order, while sector-wide stock prices have plunged and 100 hospital officials placed under investigation, shocking the industry.

China Commercial Compliance

Heat On E-Pharmacies In India -The Shape Of Things To Come

India is expected to rein in the ‘unfettered’ run of e-pharmacies, a segment where top Indian conglomerates and Amazon have made strides, with pharma intertwined having tapped into these platforms. Scrip speaks to experts on areas of concern including prescription ‘workarounds’, supply chain transparency and data privacy where more oversight is called for amid the evolving regulatory landscape.

Regulation E-Commerce India